London Office | email@example.com | +44 (0) 207 451 4558
Will Arnold, a Vice President at Torreya, provides transaction support on a variety of European investment banking assignments. Will has worked on several transactions, including the sale of Bio Products Laboratory to Creat Group Corporation and the Vectura/Skyepharma merger.
He joined Torreya in 2016. Previously, Will worked at Lazard as an Associate in the healthcare investment banking team.
Will is a chartered accountant and holds a B.Sc. in biological sciences from the University of Bristol.
|sale of Yargesa to|